The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Epigenetic regulation of miR-21 in colorectal cancer: ITGB4 as a novel miR-21 target and a three-gene network (miR-21-ITGΒ4-PDCD4) as predictor of metastatic tumor potential
Open accessAbstract
Previous studies have uncovered several transcription factors that determine biological alterations in tumor cells to execute the invasion-metastasis cascade, including the epithelial-mesenchymal transition (EMT). We sought to investigate the role of miR-21 in colorectal cancer regulation. For this purpose, miR-21 expression was quantified in a panel of colorectal cancer cell lines and clinical specimens. High expression was found in cell lines with EMT properties and in the vast majority of human tumor specimens. We demonstrate in a cell-specific manner the occupancy of MIR-21 gene promoter by AP-1 and ETS1 transcription factors and, for the first time, the pattern of histone posttranslational modifications necessary for miR-21 overexpression. We also show that Integrin-β4 (ITGβ4), exclusively expressed in polarized epithelial cells, is a novel miR-21 target gene and plays a role in the regulation of EMT, since it is remarkably de-repressed after transient miR-21 silencing and downregulated after miR-21 overexpression. miR-21-dependent change of ITGβ4 expression significantly affects cell migration properties of colon cancer cells. Finally, in a subgroup of tumor specimens, ROC curve analysis performed on quantitative PCR data sets for miR-21, ITGβ4, and PDCD4 shows that the combination of high miR-21 with low ITGβ4 and PDCD4 expression is able to predict presence of metastasis. In conclusion, miR-21 is a key player in oncogenic EMT, its overexpression is controlled by the cooperation of genetic and epigenetic alterations, and its levels, along with ITGβ4 and PDCD4 expression, could be exploited as a prognostic tool for CRC metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“miRNAs play a key role in the progression of malignant tumors, they are considered potential anti-tumor therapeutic targets24, 25.”
From miR-21-5p Inhibits the Proliferation, Migration, and Invasion of Glioma by Targeting S100A10 (2023) · cites this paper as [25]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1997 · Cited by 7,668
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R., Côme, C., Savagner, P., Gitelman, I., Richardson, A. L., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,917
Cano, A., Pérez‐Moreno, M., Rodrigo, I., Locascio, A., Blanco, M. J., Barrio, M. G. D., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,672
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Research works printed but not linked: 2
- Voulgari A, 2009, Biochim Biophys Acta, 1796, 75
- Falcioni R, 1994, Int J Oncol, 5, 573
Cited by
Sorted by citations
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer
Lan, J., Sun, L., Xu, F., Liu, L., Hu, F., Song, D., Hou, Z., Wu, W., Luo, X., Wang, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0014 · Cited by 643
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics
Bautista-Sánchez, D., Arriaga-Canon, C., Pedroza-Torres, A., De La Rosa-Velázquez, I. A., González-Barrios, R., Contreras-Espinosa, L., Montiel-Manríquez, R., Castro-Hernández, C., Fragoso-Ontiveros, V., Álvarez-Gómez, R. M., et al. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.03.003 · Cited by 549
“,(76) it was found that histone posttranslational modifications such as H3K27me3 and H3K9me2 were completely absent, whereas the marks related to active transcription, H3K9-14ac, H3K4me3, and H3K27ac, were higher on the promoter of miR-21 in cell lines with an epithelial-mesenchymal transition (EMT) phenotype.(76) How…”
BackgroundRegulation of EMT in Colorectal Cancer: A Culprit in Metastasis
Vu, T., & Datta, P. K. (2017) · Cancers · doi:10.3390/cancers9120171 · Cited by 510
“miR-200 family P53/ZEB1/SIX1 ZEB1, ZEB2 [125,126] miR-429 P53/ZEB1/SIX1 HOXA5 [159] miR-34a SNAIL, ZEB1, IL-6/STAT3 SLUG, ZEB1, IL-6R [134,135] miR-9 N/A E-Cadherin [58] miR-21 AP-1/ETS1 ITGβ4 [150] miR-138 N/A TWIST2 [137] miR-132 N/A ZEB2 [131] miR-30b N/A SIX1 [139] miR-598 N/A JAG1/Notch2 [141] miR-4775 N/A TGFβ […”
BackgroundInfluentialEpithelial–mesenchymal transition in colorectal cancer metastasis: A system review
Cao, H., Xu, E., Liu, H., Wan, L., & Lai, M. (2015) · Pathology - Research and Practice · doi:10.1016/j.prp.2015.05.010 · Cited by 367
Qiu, G., Jin, M., Dai, J., Sun, W., Feng, J., & Jin, W. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.002 · Cited by 250
Overview upon miR-21 in lung cancer: focus on NSCLC
Bica, C., Cojocneanu, R., Magdo, L., Ráduly, L., Gulei, D., & Berindan‐Neagoe, I. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2877-x · Cited by 235
Hashemi, M., Mirdamadi, M. S. A., Talebi, Y., Khaniabad, N., Banaei, G., Daneii, P., Gholami, S., Ghorbani, A., Tavakolpournegari, A., Farsani, Z. M., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2022.106568 · Cited by 153
The opposing roles of laminin-binding integrins in cancer
Ramovš, V., Molder, L. T., & Sonnenberg, A. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.08.007 · Cited by 161
“miR-221 and miR-222 resulted in reduced β4 expression, which was partially responsible for impaired invasion of breast cancer cells [367], while in the absence of miR-21 a higher expression level of β4 was correlated with a reduction in the rate of colorectal cancer cell migration [366].”
BackgroundMicroRNAs in the etiology of colorectal cancer: Pathways and clinical implications
Strubberg, A. M., & Madison, B. B. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027441 · Cited by 147
Epigenetics and MicroRNAs in Cancer
Ramassone, A., Pagotto, S., Veronese, A., & Visone, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020459 · Cited by 152
Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer
Diamantopoulos, M. A., Tsiakanikas, P., & Scorilas, A. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.06.10 · Cited by 139
An amplification-free electrochemical detection of exosomal miRNA-21 in serum samples
Boriachek, K., Umer, M., Islam, M. N., Gopalan, V., Lam, A. K.-Y., Nguyen, N., & Shiddiky, M. J. A. (2018) · The Analyst · doi:10.1039/c7an01843f · Cited by 133
MiR-21: an environmental driver of malignant melanoma?
Melnik, B. C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0570-5 · Cited by 131
Far, B. F., Vakili, K. G., Fathi, M., Yaghoobpoor, S., Bhia, M., & Naimi‐Jamal, M. R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121340 · Cited by 115
The Role of microRNA-21 in the Onset and Progression of Cancer
Singh, A. K., Singh, A. K., Giri, R., Kumar, D., Sharma, R., Vališ, M., Kuča, K., & Garg, N. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0096 · Cited by 81
Li, C., Zhao, L., Chen, Y., He, T., Chen, X., Mao, J., Li, C., Lyu, J., & Meng, Q. H. (2016) · BMC Cancer · doi:10.1186/s12885-016-2628-z · Cited by 76
Xiang, J., Bian, C., Wang, H., Huang, S., & Wu, D. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0125-x · Cited by 74
“More interestingly, the roles of miRNA have proven to be indispensable in affecting cancer biology, including proliferation, autophagy, apoptosis, and invasiveness [10-14].”
ITGB4 is a novel prognostic factor in colon cancer
Li, M., Jiang, X., Wang, G., Zhai, C., Liu, Y., Li, H., Zhang, Y., Yu, W., & Zhao, Z. (2019) · Journal of Cancer · doi:10.7150/jca.29269 · Cited by 73
“have suggested that ITGB4 was a target of miR-21 and regulated by miR-21 in colon cancer [30].”
BackgroundThe use of circulating microRNAs as diagnostic biomarkers in colorectal cancer
Clancy, C., Joyce, M., & Kerin, M. J. (2015) · Cancer Biomarkers · doi:10.3233/cbm-140456 · Cited by 67
“It is a key regulator of oncogenic Epithelial-Mesenchymal Transition (EMT) targeting proteins such as T-Cell Lymphoma Invasion and Meta-stases Inducing Protein-1 (TIAM1) which is known to regulate migration and invasion of cancer cells [34,35].”
Targeting strategies on miRNA-21 and PDCD4 for glioblastoma
Wang, G., Wang, J. J., Tang, H., & To, S. S. T. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.07.001 · Cited by 67
Kalmár, A., Péterfia, B. F., Hollósi, P., Galamb, O., Spisák, S., Wichmann, B., Bodor, A., Tóth, K., Patai, Á. V., Valcz, G., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1687-x · Cited by 61
Nguyen, H. T., Kacimi, S. E. O., Nguyen, T. L., Suman, K. H., Lemus-Martin, R., Saleem, H., & Do, D. N. (2021) · Biology · doi:10.3390/biology10050417 · Cited by 62
“Ferraro and colleagues, for example, demonstrated that Activator protein 1 (AP-1) and ETS Proto-Oncogene 1 (ETS1) TFs negatively regulate the expression of miR-21 gene by occupying its promoter in a sequence-specific manner [18].”
BackgroundBeaulieu, J. (2019) · Cancers · doi:10.3390/cancers12010041 · Cited by 57
“Epigenetic regulation of ITGB4 expression has also been suggested after identification of microRNAs that may target the ITGB4 transcript such as miR-21 [33] and miR-335-5p [32] as well as hypomethylation of the ITGB4 promoter [32].”
BackgroundClassification of gene signatures for their information value and functional redundancy
Cantini, L., Calzone, L., Martignetti, L., Rydenfelt, M., Blüthgen, N., Barillot, E., & Zinovyev, A. Y. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0038-8 · Cited by 54
“31,32 Moreover, the areas: splicing, mRNA metabolism, and protein metabolism, resulted to be signi fi cantly upregulated.”
BackgroundCellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 56
Regulation of hemidesmosome dynamics and cell signaling by integrin α6β4
Molder, L. T., de Pereda, J. M., & Sonnenberg, A. (2021) · Journal of Cell Science · doi:10.1242/jcs.259004 · Cited by 54
Malik, D.-E.-S., David, R. M., & Gooderham, N. J. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2291-z · Cited by 52
Effects of pericytes and colon cancer stem cells in the tumor microenvironment
Garza-Treviño, E. N., González, P. D., Salgado, C. I. V., & Garza, A. M. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0888-9 · Cited by 53
Bera, A., Das, F., Ghosh‐Choudhury, N., Kasinath, B. S., Abboud, H. E., & Choudhury, G. G. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.06.022 · Cited by 54
Wang, W., Li, H., Yu, J., Han, X.-P., Xu, Z., Li, Y., Jiao, Z.-Y., & Liu, H. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.09.053 · Cited by 51
Liu, Z., Sun, T., Piao, C., Zhang, Z., & Kong, C. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00831-5 · Cited by 50
miR-339-3p inhibits proliferation and metastasis of colorectal cancer
Zhou, C., LU, Y., & Li, X. (2015) · Oncology Letters · doi:10.3892/ol.2015.3661 · Cited by 50
Ding, T., Cui, P., Zhou, Y., Chen, C., Zhao, J., Wang, H., Guo, M., He, Z., & Xu, L. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.09.004 · Cited by 50
“For instance, Ferraro et al.(42) reported that miR-21 could regulate the metastasis of CRC cells through ITGB4 expression”
BackgroundInfluentialTian, L., Shan, W., Zhang, Y., Lv, X., Li, X., & Wei, C. (2015) · Pathology & Oncology Research · doi:10.1007/s12253-015-9979-7 · Cited by 49
“cancer [17], prognostic cancer [16], gastric cancer [16] and et al.”
MicroRNA-21 controls hTERT via PTEN in human colorectal cancer cell proliferation
Yang, Y., Yang, J., Tao, H., & Jin, W.-S. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0380-5 · Cited by 48
Hippo kinases regulate cell junctions to inhibit tumor metastasis in response to oxidative stress
Wang, Y., Li, J., Gao, Y., Luo, Y., Luo, H., Wang, L., Yi, Y., Yuan, Z., & Xiao, Z. J. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101233 · Cited by 47
Jin, X., Lu, S., & Wang, A. (2020) · BMC Cancer · doi:10.1186/s12885-020-06715-6 · Cited by 47
miR-21: A Key Small Molecule with Great Effects in Combination Cancer Therapy
Arghiani, N., & Matin, M. M. (2021) · Nucleic Acid Therapeutics · doi:10.1089/nat.2020.0914 · Cited by 47
“It has been demonstrated that inhibition of MSH2 by miR-21 confers TGF-b -induced resistance to PARP inhibitor (PARPi), which selectively targets tumor cells with a DNA repair deficiency, in breast cancer cells [117].”
The role of miRNA-21 and epithelial mesenchymal transition (EMT) process in colorectal cancer
Jaca, A., Govender, P., Locketz, M. L., & Naidoo, R. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2016-204031 · Cited by 41
The mechanisms and clinical significance of PDCD4 in colorectal cancer
Long, J., Yin, Y., Guo, H., Li, S., Sun, Y., Zeng, C., & Zhu, W. (2018) · Gene · doi:10.1016/j.gene.2018.09.034 · Cited by 40
Bahreyni, A., Rezaei, M., Bahrami, A., Khazaei, M., Fiuji, H., Ryzhikov, M., Ferns, G. A., Avan, A., & Hassanian, S. M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27580 · Cited by 39
“ROC curve analysis validated that the combination of high miR‐21 with low ITGβ4 and PDCD4 expression may be considered as a factor indicating metastasis in CRC (Ferraro et al., 2014).”
BackgroundEpigenetic alterations in cancer and personalized cancer treatment
Miozzo, M. R., Vaira, V., & Sirchia, S. M. (2015) · Future Oncology · doi:10.2217/fon.14.237 · Cited by 37
Kaller, M., & Hermeking, H. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-42059-2_4 · Cited by 36
Downregulation of miR-21 as a promising strategy to overcome drug resistance in cancer
Akhtarkhavari, T., Bahrami, A. R., & Matin, M. M. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175233 · Cited by 38
Berberine regulates the microRNA‑21‑ITGΒ4‑PDCD4 axis and inhibits colon cancer viability
L�, Y., Han, B., Yu, H., Cui, Z., Li, Z., & Wang, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.7997 · Cited by 34
“…and a transmembrane domain, and the intracellular region ITG β 4 determines the specificity to physiological and pathological processes, including the inflammatory response, the immune response, proliferation, differentiation, vascularization, fertilization, embryo implantation and growth (29).”
microRNAs as therapeutic targets in intestinal diseases
Wang, C., & Chen, J. (2019) · ExRNA · doi:10.1186/s41544-019-0026-9 · Cited by 33
“As the well-studied miRNA, miR-21 is almost omnipresent overexpressed in many human tumours, such as colorectal cancer [109, 110].”
BackgroundYu, Y., Chen, Z., Liu, H., Jin, W., Ding, Z., & Zheng, S. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s103893 · Cited by 30
“28 Emerging studies have demonstrated that aberrant expression of miRNAs is associated with prognosis of CRC.”
InfluentialThe role of microRNAs involved in PI3‐kinase signaling pathway in colorectal cancer
Noorolyai, S., Mokhtarzadeh, A., Baghbani, E., Asadi, M., Baghbanzadeh, A., Moghaddam, M. M., & Baradaran, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27415 · Cited by 30
Yamada, H., Suzuki, K. A. O., Fujii, R., Kawado, M., Hashimoto, S., Watanabe, Y., Iso, H., Fujino, Y., Wakai, K., & Tamakoshi, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-84707-7 · Cited by 30
Roles of Integrins in Gastrointestinal Cancer Metastasis
Hou, S., Wang, J., Li, W., Hao, X., & Hang, Q. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.708779 · Cited by 34
Tsiakanikas, P., Kontos, C. K., Kerimis, D., Papadopoulos, I. N., & Scorilas, A. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0430 · Cited by 27
Self-citationTsiakanikas, P., Adamopoulos, P. G., Tsirba, D., Artemaki, P. I., Papadopoulos, I. N., Kontos, C. K., & Scorilas, A. (2022) · Biomedicines · doi:10.3390/biomedicines10051120 · Cited by 27
“Due to the cellular dynamics of tsRNAs, it is speculated that they play a key role in the epigenetic regulation of the protein-coding genes, using RNA interference (RNAi) in a similar way to other sncRNAs such as miRNAs and piRNAs [38,39].”
BackgroundSelf-citationIntegrin β4 as a Potential Diagnostic and Therapeutic Tumor Marker
Yang, H., Xu, Z., Peng, Y., Wang, J., & Xiang, Y. (2021) · Biomolecules · doi:10.3390/biom11081197 · Cited by 28
“Therefore, except for indicating cancer progression by integrin β4, the combination of high miR-21 and low ITGβ4 and PDCD4 expression can predict the presence of metastasis and can be used as a predictive tool for colorectal cancer metastasis [77].”
BackgroundJin, D.-J., Fang, Y., Li, Z., Chen, Z., & Xiang, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3638 · Cited by 27
Li, Y., Ye, J., Xu, S., & Wang, J. (2023) · Discover Oncology · doi:10.1007/s12672-023-00686-3 · Cited by 27
KH-type splicing regulatory protein is involved in esophageal squamous cell carcinoma progression
Fujita, Y., Masuda, K., Hamada, J., Shoda, K., Naruto, T., Hamada, S., Miyakami, Y., Kohmoto, T., Watanabe, M., Takahashi, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20926 · Cited by 25
“In this study, we report that KHSRP exerts oncogenic activity in ESCC cells, at least partly, by inducing the expression of a set of oncogenic miRNAs, including miR-21, miR-130b, and miR-301a, and by suppressing the downstream inhibitors of epithelial-tomesenchymal transition (EMT), such as BMP6, PDCD4, and TIMP3, res…”
BackgroundInfluentialAdamopoulos, P. G., Theodoropoulou, M. C., & Scorilas, A. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.06.32 · Cited by 25
Jorgensen, B. G., & Ro, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042166 · Cited by 24
miR-21-5p Inhibits the Proliferation, Migration, and Invasion of Glioma by Targeting S100A10
Gao, P., Wang, H., Li, H., Shu, L., Han, Z., Li, S., Cheng, H., & Dai, X. (2023) · Journal of Cancer · doi:10.7150/jca.84030 · Cited by 22
“miRNAs play a key role in the progression of malignant tumors, they are considered potential anti-tumor therapeutic targets[24, 25].”
BackgroundRavegnini, G., Moraga, J. M. Z., Maffei, F., Musti, M. A., Zenesini, C., Simeon, V., Sammarini, G., Festi, D., Hrelia, P., & Angelini, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226113 · Cited by 22
“Besides genetic events, epigenetic changes, including DNA methylation, histone modifications, and deregulation of non-coding RNAs may play a crucial role in tumor progression [8,9].”
ITGB4 as a novel serum diagnosis biomarker and potential therapeutic target for colorectal cancer
Jiang, X., Wang, J., Wang, M., Xuan, M., Han, S., Li, C., Li, M., Sun, X., Yu, W., & Zhao, Z. (2021) · Cancer Medicine · doi:10.1002/cam4.4216 · Cited by 22
Liu, J., Zhai, R., Zhao, J., Kong, F., Wang, J., Jiang, W., Xin, Q., Xue, X., & Luan, Y. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4303 · Cited by 21
“A variety of apoptosis inducers upregulate the expression of PDCD4, thus affecting multiple signaling pathways (7-9).”
Newie, I., Søkilde, R., Persson, H., Jacomasso, T., Gorbatenko, A., Borg, Å., de Hoon, M., Pedersen, S. F., & Rovira, C. (2016) · Scientific Reports · doi:10.1038/srep35664 · Cited by 20
Hou, Z., & Quan, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6363 · Cited by 19
miR-21 expression analysis in budding colon cancer cells by confocal slide scanning microscopy
Nguyen, K., Lindebjerg, J., Kalmár, A., Molnar, B. A., Sørensen, F. B., Hansen, T. F., & Nielsen, B. S. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9945-3 · Cited by 19
“Kang et al. found that high stromal miR-21 and low E-cadherin was correlated [10].”
BackgroundInfluentialmiR-30c-5p inhibits glioma proliferation and invasion via targeting Bcl2
Yuan, L., Zhang, T., Xu, L., Han, H., & Liu, S. (2021) · Translational Cancer Research · doi:10.21037/tcr-19-2957 · Cited by 18
Epigenetically regulated microRNAs and their prospect in cancer diagnosis
Kita, Y., Vincent, K. D., Natsugoe, S., Berindan‐Neagoe, I., & Călin, G. A. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.925399 · Cited by 17
“miR-21 Histone post-translational modification Breast, prostate, glioblastoma Overexpressed/ oncogenic P53, TPM1, PDCD4 ITGb4 and PDCD4 expression [80,81]”
The mechanism of ITGB4 in tumor migration and invasion
Huang, G., Zhou, M., Lu, D., Li, J., Tang, Q., Xiong, C., Liang, F., & Chen, R. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1421902 · Cited by 16
“Additionally, the microRNA miR-21 has been shown to regulate the colorectal cancer invasion-metastasis cascade by targeting ITGB4 (54).”
BackgroundChen, X., Xie, B., Cao, L., Zhu, F., Chen, B., Lv, H., Fan, X., Han, L., Bie, L., Cao, X., et al. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.02.004 · Cited by 16
Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer
Huang, R., Zheng, Z., Xian, S., Zheng, Z., Jia, J., Song, D., Yan, P., Yin, H., Hu, P., Zhu, X., et al. (2021) · Bioengineered · doi:10.1080/21655979.2021.1964252 · Cited by 15
Kourtis, A., Adamopoulos, P. G., Papalois, A. E., Iliopoulos, D., Babis, G. C., & Scorilas, A. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.05.47 · Cited by 15
“To date, several miRNAs have been shown to regulate expression of BCL2L12 and/or other members of the BCL2 family; most of them constitute important biomarkers (48,72-81).”
BackgroundMa, D., Liu, S., Liu, K., Kong, L., Xiao, L., Xin, Q., Jiang, C., & Wu, J. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2314324 · Cited by 14
Gelfand, R., Vernet, D. A., Bruhn, K. W., Vadgama, J. V., & González-Cadavid, N. F. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3461 · Cited by 14
“As in the case of members of the TGFß family, some integrins such as integrin β4 go in the opposite direction of some of the other integrins, such as β8 or A3, but in addition, these effects may be associated with potential metastatic ability, since the combination of low ITGβ4, exclusively expressed in polarized epit…”
BackgroundYu, L., Liang, X., Wang, J., Ding, G., Tang, J., Xue, J., He, X. Q., Ge, J., Jin, X., Yang, Z., et al. (2023) · Genetics Research · doi:10.1155/2023/6782732 · Cited by 14
Jepsen, R. K., Novotny, G. W., Klarskov, L. L., Christensen, I. J., Høgdall, E. V. S., & Riis, L. B. (2016) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2016.08.003 · Cited by 13
Adamopoulos, P. G., Tsiakanikas, P., & Scorilas, A. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0342 · Cited by 13
Programmed cell death factor 4 enhances the chemosensitivity of colorectal cancer cells to Taxol
Wang, D., Hou, Q., Zhao, L., Gao, J., Xiao, Y., & Wang, A. (2019) · Oncology Letters · doi:10.3892/ol.2019.10398 · Cited by 15
Papachristopoulou, G., Malachias, A., Devetzi, M., Kamouza, E., Scorilas, A., Xynopoulos, D., & Talieri, M. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-1010 · Cited by 13
MicroRNA Expression and Correlation with mRNA Levels of Colorectal Cancer-Related Genes
Moghadamnia, F., Ghoraeian, P., Minaeian, S., Talebi, A., Farsi, F., & Akbari, A. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-019-00249-2 · Cited by 12
“According to previous investigations, expression levels of the miR-21 molecule were the highest in invasive carcinomas and gradually decreased towards non-transformed tissue [32, 33].”
ResultZheng, H., Clausse, V., Amarasekara, H., Mazur, S. J., Botos, I., & Appella, D. H. (2023) · JACS Au · doi:10.1021/jacsau.3c00198 · Cited by 13
Chen, Y., Liu, M., Hu, J., Peng, B., Dai, L., Wang, S., Xing, H., Wang, B., & Wu, Z. H. (2021) · BioMed Research International · doi:10.1155/2021/6529255 · Cited by 11
Chen, Y., Wang, R., Dashwood, W., Löhr, C. V., Williams, D. E., Ho, E., Mertens‐Talcott, S. U., & Dashwood, R. H. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1945-6 · Cited by 12
“2014), epithelial-to-mesenchymal transition (Ferraro et al. 2014), and chemoresistance (Chao et al.”
Relationship between the microRNAs and PI3K/AKT/mTOR axis: Focus on non-small cell lung cancer
Lin, Y., Zhang, L., Ding, X., Chen, C., Meng, M., Ke, Y., & Wang, W. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154093 · Cited by 10
King, L. E., Zhang, H., Gould, C. M., Thomas, D. W., Whitehead, L. W., Simpson, K. J., Burgess, A. W., & Faux, M. C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240746 · Cited by 10
MiR-486-5p Downregulation Marks an Early Event in Colorectal Carcinogenesis
Kelley, K. A., Wieghard, N., Chin, Y., Potter, A. B., Mori, M., Wong, M. H., Chin, K., & Tsikitis, V. L. (2018) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001192 · Cited by 9
Karamagkiolas, S., Giotakis, I., Kyrodimos, E., Giotakis, E. I., Kataki, A., Karagianni, F., & Lazaris, A. M. (2019) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2019.04.002 · Cited by 9
Pantazis, T.-L., Giotakis, A. Ι., Karamagkiolas, S., Giotakis, I., Konstantoulakis, M. M., Liakea, A., & Misiakos, E. P. (2020) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2020.102563 · Cited by 9
Christodoulou, S., Katsaraki, K., Vassiliu, P., Danias, N., Michalopoulos, N. V., Tzikos, G., Sideris, D. C., & Arkadopoulos, N. F. (2023) · Biomedicines · doi:10.3390/biomedicines11071945 · Cited by 8
Natural compounds as regulators of miRNAs: exploring a new avenue for treating colorectal cancer
Doghish, A. S., Mageed, S. S. A., Mohammed, O. A., Abdel‐Reheim, M. A., Zaki, M. B., Mohamed, A. H., Rizk, N. I., Abulsoud, A. I., Abdelmaksoud, N. M., El‐Dakroury, W. A., et al. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01547-8 · Cited by 7
“In addition, miR-21 could aggravate CRC by potentiating EMT through inactivating Integrin-β4 (ITGβ4), and Programmed cell death protein 4 (PDCD4) (Ferraro et al. 2014).”
Molecular therapies delaying cardiovascular aging: disease- or health-oriented approaches
Magenta, A., Lorde, R., Syed, S. B., Capogrossi, M. C., Puca, A. A., & Madeddu, P. R. (2020) · Vascular Biology · doi:10.1530/vb-19-0029 · Cited by 6
Christodoulou, S., Sotiropoulou, C. D., Vassiliu, P., Danias, Ν., Arkadopoulos, N. F., & Sideris, D. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129990 · Cited by 6
Stem Cell-Like Properties of CK2β-down Regulated Mammary Cells
Duchemin-Pelletier, E., Baulard, M., Spreux, E., Orhant‐Prioux, M., Burute, M., Mograbi, B., Guyon, L., Théry, M., Cochet, C., & Filhol, O. (2017) · Cancers · doi:10.3390/cancers9090114 · Cited by 6
“As mentioned above, integrins are also regulated by miRNAs [24].”
BackgroundHan, Y., Wang, L., & Wang, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.919965 · Cited by 6
Xia, W., Zhang, L.-H., & Liu, Y. (2019) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2019.0122 · Cited by 6
Yang, Q., Chen, K., Chen, S., Wang, Y., Xia, Y., Chen, J., & Shen, Y. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117584 · Cited by 5
The impact of microRNAs on myeloid-derived suppressor cells in cancer
Baghbani, E., Noorolyai, S., Duijf, P. H. G., Silvestris, N., Kolahian, S., Hashemzadeh, S., Baghbanzadeh, A., FallahVazirabad, A., & Baradaran, B. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.04.009 · Cited by 5
Ali, Y. B. M., Thabet, M., El-Maghraby, A. M., Gomaa, A. I., Khamiss, O., & Talaat, R. M. (2022) · Journal of Bioscience and Applied Research/Journal of Bioscience and Applied Research · doi:10.21608/jbaar.2022.260856 · Cited by 2
Parsyan, A. E., Robichaud, N., & Meterissian, S. H. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_29 · Cited by 2
Machine Learning-based Prediction of the Likelihood of Colorectal Cancer Using miRNA Expression
Sultan, A., de Asa, A. A., Guimbangunan, T. M., Serapio, E. D., Fellizar, A., Albano, P. M., & Tomas, R. C. (2023) · The Philippine journal of science · doi:10.56899/152.04.12 · Cited by 2
Shabab, N., Afshar, S., & Saidijam, M. (2019) · Avicenna Journal of Medical Biochemistry · doi:10.34172/ajmb.2019.05 · Cited by 1
“The miR 21 is a specific miRNA which was upregulated in many epithelial-derived cancers including breast, pancreas, lung, gastric, prostate, and colon cancers (33-35).”
Background
Metadata
- Authors
- Ferraro, A., Kontos, C. K., Boni, T., Bantounas, I., Siakouli, D., Kosmidou, V., Vlassi, M., Spyridakis, Y., Tsipras, I., Zografos, G., & Pintzas, A.
- Affiliations
- National Hellenic Research Foundation (GR)
- General Hospital of Athens G. Genimatas (GR)
- Corresponding author
- Pintzas, Alexander
- ORCID
- Venue
- Epigenetics
- Publisher
- Informa UK Limited
- Published
- 2013-10-22
- Volume
- 9
- Issue
- 1
- Pages
- 129-141
- ISSN
- 1559-2294 (ISSN-L)
- 1559-2308
- PMC
- PMC3928175
- OpenAlex
- W2090786568
- Cited by
- 111
- References
- 66
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 5 · 2023: 8 · 2022: 8 · 2021: 14 · 2020: 6 · 2019: 11 · 2018: 19 · 2017: 10 · 2016: 9 · 2015: 11 · 2014: 4
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Epigenetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation) (submittedVersion)
- Funders
- General Secretariat for Research and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- miR-21, colorectal cancer, epithelial-mesenchymal transition, ITGB4, PDCD4, histone modifications, AP-1 transcription factor, Ets-1 transcription factor, cell migration, metastasis prediction, prognostic factors, microRNA overexpression
- MeSH terms
- Histones, Humans, Neoplasm Metastasis, Protein Processing, Post-Translational, Biomarkers, Tumor, Colorectal Neoplasms, RNA-Binding Proteins, Transcription Factor AP-1, MicroRNAs, Integrin beta4, Epigenesis, Genetic, Cell Line, Tumor, Proto-Oncogene Protein c-ets-1, Apoptosis Regulatory Proteins, Gene Regulatory Networks, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
